CHANGE IN QUALITY OF LIFE OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER HEPATECTOMY AT UNIVERSITY MEDICAL CENTER HO CHI MINH CITY

Thị Thanh Trúc Nguyễn, Thị Như Xuân Hà, Nguyên Trung Võ , Mạnh Hùng Cao, Thị Diệu Hiền Lê, Thị Yến Linh Mai, Thị Ngọc Kiều Mai, Thị Sơn Trang Nguyễn

Main Article Content

Abstract

Objectives: Assessing the quality of life (QoL) of patients with hepatocellular carcinoma (HCC) at one week and one month after hepatectomy at University Medical Center Ho Chi Minh City. Methods: Cross-sectional descriptive study on 112 patients with HCC treated by hepatectomy at the Department of Hepatobiliary Pancreatic Surgery, University Medical Center Ho Chi Minh City on QoL at 1 week and 1 month after surgery, during the period from November 2023 to March 2024, meets the sampling criteria and agrees to participate in the study. Results: The patient's average QoL score according to the QLQ-C30 scale 1 week after surgery was 75.02±9.80 and after 1 month was 86.01±7.11 points, an increase of 10.98±7.81 points. Conclusions: The average QoL score of patients with HCC 1 week after hepatectomy was relatively good and had a significant increase 1 month after surgery, showing the effectiveness of treatment intervention and post-operative care

Article Details

References

1. Hong SK, Lee KW, Hong S young, et al. Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database. Front Oncol. 2021;11. Accessed May 9, 2023. https://www.frontiersin. org/articles/10.3389/fonc.2021.674603
2. Su YM, Liu W, Yan XL, et al. Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Med. 2023;12(8):9559-9569. doi:10.1002/ cam4.5732
3. Wee IJY, Syn N, Lee LS, Tan SS, Chiow AKH. A systematic review and meta-analysis on the quality of life after hepatic resection. HPB. 2020; 22(2): 177-186. doi:10.1016/j.hpb. 2019.11.016.
4. Li L, Chan SL, Mo F, et al. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2019; 28(9): 2597-2607. doi:10.1007/s11136-019-02190-0.
5. Li L, Mo FKF, Chan SL, et al. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data. BMC Cancer. 2017/01/04 2017;17(1):8. doi:10.1186/s12885-016-2995-5
6. Kirchner T, Marquardt S, Werncke T, et al. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma. Abdominal Radiology. 2019/04/01 2019;44(4):1554-1561. doi:10.1007/ s00261-018-1802-y.
7. Hu J, Yang J, Yu H, et al. Effect of Sarcopenia on Survival and Health-Related Quality of Life in Patients with Hepatocellular Carcinoma after Hepatectomy. Cancers. 2022;14(24):6144. doi:10. 3390/cancers14246144.